Tobin Schilke Appointed Achaogen CFO
Achaogen Inc. a biopharma developing antibacterial addressing multi-drug resistant gram-negative infections, has appointed Tobin Schilke chief financial officer (CFO). For 13 years Schilke was at Roche/Genentech where he was most recently CFO and company director of Roche Products Limited in the United Kingdom.
You may also be interested in...
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
Plus Sanofi and Translate Bio release preclinical data from their COVID-19 vaccine candidate, another entrant to the now crowded mRNA vaccine field.
NIH study of monoclonal antibody therapy in combination with Gilead's remdesivir paused for safety reasons.